Summary
This narrative review by Mesnage and Antoniou critically examines the scientific literature underpinning the debate over glyphosate's toxicity, distinguishing well-supported findings from those it characterises as methodologically flawed or overstated. The authors, known for scepticism of industry-aligned safety conclusions, likely argue that regulatory assessments have underweighted evidence of potential harm, particularly regarding carcinogenicity and endocrine disruption. Published in Frontiers in Public Health, the paper contributes to ongoing scientific and regulatory controversy surrounding glyphosate, the world's most widely used herbicide.
UK applicability
Glyphosate is widely used in UK arable and horticultural systems, and its regulatory status has been subject to review by the UK Health Security Agency and HSE post-Brexit; the arguments raised in this paper are directly relevant to UK re-authorisation debates and residue monitoring policy.
Key measures
Assessment of epidemiological and toxicological evidence; evaluation of regulatory risk assessments; scrutiny of study methodology and data interpretation in the glyphosate literature
Outcomes reported
The paper evaluates contested claims surrounding glyphosate's toxicity, examining the scientific evidence for and against associations with cancer, endocrine disruption, and other health endpoints. It assesses the quality and interpretation of studies cited in the glyphosate safety debate.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.